Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Income Statement

Earnings Waterfall
Hyloris Pharmaceuticals SA

Revenue
2.1m EUR
Cost of Revenue
-93k EUR
Gross Profit
2m EUR
Operating Expenses
-17.8m EUR
Operating Income
-15.8m EUR
Other Expenses
466k EUR
Net Income
-15.4m EUR

Income Statement
Hyloris Pharmaceuticals SA

Rotate your device to view
Income Statement
Currency: EUR
Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
1
N/A
3
+233%
3
+6%
1
-73%
2
+129%
2
+1%
Gross Profit
Cost of Revenue
(0)
(0)
(0)
(0)
(0)
(0)
Gross Profit
1
N/A
3
+250%
3
+6%
1
-75%
2
+138%
2
+4%
Operating Income
Operating Expenses
(11)
(13)
(10)
(12)
(20)
(18)
Selling, General & Administrative
(1)
(3)
(3)
(4)
(6)
(6)
Research & Development
(4)
(5)
(8)
(10)
(17)
(14)
Other Operating Expenses
(5)
(5)
0
1
3
2
Operating Income
(10)
N/A
(10)
-6%
(7)
+29%
(12)
-57%
(19)
-61%
(16)
+14%
Pre-Tax Income
Interest Income Expense
(2)
(1)
(0)
(0)
0
1
Non-Reccuring Items
0
(0)
0
0
0
0
Total Other Income
0
(0)
(0)
(0)
0
(0)
Pre-Tax Income
(12)
N/A
(11)
+3%
(8)
+29%
(12)
-49%
(19)
-56%
(15)
+17%
Net Income
Tax Provision
0
(0)
(0)
(0)
(0)
0
Income from Continuing Operations
(12)
(12)
(8)
(12)
(19)
(15)
Net Income (Common)
(12)
N/A
(12)
+1%
(8)
+28%
(12)
-44%
(19)
-56%
(15)
+17%
EPS (Diluted)
-0.45
N/A
-0.45
N/A
-0.32
+29%
-0.44
-38%
-0.68
-55%
-0.55
+19%

See Also

Discover More